The function changes of HPA axis in diabetic rat model induced by high lipid food plus STZ and relation with glucose and lipid metabolism

Chinese Pharmacological Bulletin

Volumn 26, Issue 3, 2010, Pages

  Wang, Li Jun ^a,b   Zhang, Ru Xue ^a   Jia, Zheng Ping ^a,b   Li, Mao Xing ^a   Qiu, Jian Guo ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Glucose and lipid metabolism; HPA axis; Modulation; Rehmannia glutinosa oligosaccharides; Streptozotocin

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOSE; INSULIN; LIPID; METFORMIN; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE METABOLISM; HYPOPHYSIS; IMMUNITY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; NONHUMAN; RAT;

EID: 77953905834     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Besedovsky H, Sorkin E. Network of immune-neuro-endocrine interactions[J]. Clin Exp Lmmunol, 1977,27(1):1-12.
2. Zhang R X, Jia Z P, Fan J J, et al. Pathogenesis of diabetes mellitus and its relationship with neuroendocrine immunomodulation network[J]. Chin J Clin Rehabil, 2005,9(15):227-30.
3. Zeng Y, Jia Z P, Zhang R X, et al. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in rats with type 2 diabetes[J]. Clin Pharmacol Bull, 2006,22(4):411-5.
4. Liang H X, Yuan H Y, Li H D, et al. Observation of stability of a simple type 2 diabetic rat model: combination of high-fat diet-fed and low-dose streptozotoc in induced diabetic rat[J]. Clin Pharmacol Bull, 2008,24(4):551-5.
5. Björntorp P, Holm G, Rosmond R. Hypothalamic arousal insulin resistance and type 2 diabetes mellitus[J]. Diabet Med, 1999,16(5):373-83.
6. Renato P, Valentina V, Mauro C, et al. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome[J]. Ann New York Acad Sci, 2006,1083:111-28.
7. Anagnostis P, Athyros V G, Tziomalos K, et al. The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis[J]. J Clin Endocrinol Metab, 2009,94(8):2692-701.
8. Hashimoto K, Murakami K, Hattori T, et al. Corticotropin releasing factor (CRF)-like immunoreactivity in the adrenal medulla[J]. Peptides, 1984,5:707-11.
9. Suda T, Tomori N, Tozawa F, et al. Distribution of immunoreactive corticotropin-releasing factor in human tissues[J]. J Clin Endocrinol Metab, 1984,59(5):861-6.
10. Chan O, Inouye K, Akirav E M, et al. Hyperactivation of the hypothalamo-pituitary-adrenal (HPA) axis in diabetes is not mediated by glucose perse[J]. Diabet, 2002,51(Suppl 2):A419.